Molecular Politics: Developing American and British Regulatory Policy for Genetic Engineering, 1972-1982University of Chicago Press, 1994年10月15日 - 591 頁 The promise of genetic engineering in the early 1970s to profoundly reshape the living world activated a variety of social interests in its future promotion and control. With public safety, gene patents, and the future of genetic research at stake, a wide range of interest groups competed for control over this powerful new technology. In this comparative study of the development of regulatory policy for genetic engineering in the United States and the United Kingdom, Susan Wright analyzes government responses to the struggles among corporations, scientists, universities, trade unions, and public interest groups over regulating this new field. Drawing on archival materials, government records, and interviews with industry executives, politicians, scientists, trade unionists, and others on both sides of the Atlantic, Molecular Politics provides a comprehensive account of a crucial set of policy decisions and explores their implications for the political economy of science. By combining methods from political science and the history of science, Wright advances a provocative interpretation of the evolution of genetic engineering policy and makes a major contribution to science and public policy studies. |
內容
Four | 4 |
One Social Interests in Promoting and Controlling Science | 19 |
Five | 22 |
Two The Social Transformation of Recombinant | 65 |
Engineering Issue 19721975 | 113 |
Initiating Government Controls in the United States | 160 |
The Politics | 221 |
Six Derailing Legislation 19771978 | 256 |
Ten Dismantling the National Institutes of Health Controls | 383 |
Eleven Dismantling the Genetic Manipulation Advisory | 406 |
Twelve Molecular Politics in a Global Economy | 438 |
Appendix A Excerpts from Transcript of the Enteric Bacteria | 457 |
Appendix B New Data on Recombinant DNA Hazards Addressed | 465 |
Notes | 475 |
Bibliography | 547 |
579 | |
Seven Revising the National Institutes of Health Controls | 281 |
Eight Operating the Genetic Manipulation Advisory | 312 |
其他版本 - 查看全部
常見字詞
Advisory Committee agencies American April Ashby bacteria biohazard biological biological containment biological warfare biomedical research Biotechnology British chair cloning coli K12 containment corporations David Baltimore debate December decisions discourse Donald Fredrickson environment environmental Escherichia coli experiments Federal Register field funding Genentech genes genetic engineering genetic engineering policy Genetic Manipulation GMAG GMAG's Halvorson Harlyn hazards Health and Safety human Ibid Institutes of Health interests Interview issues July laboratory legislation levels Maxine Singer meeting ment molecular biology National Institutes Nature NIH controls NIH guidelines NIH policy Office ORDAR organisms participants pathogens Paul Berg phage plasmid policymaking political polyoma DNA potential problem production proposed RDHC Recombinant DNA Research recombinant DNA technology regulation regulatory research and development response risk assessment Safety Executive science and technology science policy scientists sector September social strains Sydney Brenner tion trade unions U.S. Government United Kingdom University virus viruses Williams committee